[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Human Coagulation Factor VIII Market Status and Outlook 2018-2025

July 2018 | 208 pages | ID: GDAD253D776EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies
  • Baxter
  • Bayer
  • CSL
  • Pfizer
  • Grifols
  • Biogen
  • Octapharma
  • NovoNordisk
  • Greencross
  • Kedrion
  • BPL
  • Hualan Bio
  • RAAS
Market by Type
  • Recombinant Factor VIII
  • Plasma-derived Factor VIII
Market by Application
  • Hemophilia A
  • Spontanous / Trauma
  • Surgical
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Human Coagulation Factor VIII Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Recombinant Factor VIII
  3.1.2 Plasma-derived Factor VIII
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hemophilia A
  4.1.2 Spontanous / Trauma
  4.1.3 Surgical
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Recombinant Factor VIII Production by Region
    6.1.1.2 Plasma-derived Factor VIII Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hemophilia A Production by Region
    6.1.2.2 Spontanous / Trauma Production by Region
    6.1.2.3 Surgical Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Recombinant Factor VIII Demand by Region
    6.2.1.2 Plasma-derived Factor VIII Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hemophilia A Demand by Region
    6.2.2.2 Spontanous / Trauma Demand by Region
    6.2.2.3 Surgical Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Baxter
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Bayer
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 CSL
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Pfizer
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Grifols
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Biogen
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Octapharma
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 NovoNordisk
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Greencross
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Kedrion
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 BPL
8.12 Hualan Bio
8.13 RAAS

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Human Coagulation Factor VIII Industry Dynamics & Regulations List
Table Global Human Coagulation Factor VIII Sales Revenue, Cost and Margin, 2015-2018E
Table Global Human Coagulation Factor VIII Market Status by Type 2015-2018E, in USD Million
Table Global Human Coagulation Factor VIII Market Status by Application 2015-2018E, in USD Million
Table Global Human Coagulation Factor VIII Market Status by Application 2015-2018E, in Volume
Table Global Human Coagulation Factor VIII Market by Region 2015-2018E, in USD Million
Table Global Human Coagulation Factor VIII Market Share by Region in 2018, in USD Million
Table Global Human Coagulation Factor VIII Market by Region 2015-2018E, in Volume
Table Global Human Coagulation Factor VIII Market Share by Region in 2018, in Volume
Table Recombinant Factor VIII Production Value by Region 2015-2018E, in USD Million
Table Recombinant Factor VIII Production Volume by Region 2015-2018E, in Volume
Table Plasma-derived Factor VIII Production Value by Region 2015-2018E, in USD Million
Table Plasma-derived Factor VIII Production Volume by Region 2015-2018E, in Volume
Table Hemophilia A Production Value by Region 2015-2018E, in USD Million
Table Hemophilia A Production Volume by Region 2015-2018E, in Volume
Table Spontanous / Trauma Production Value by Region 2015-2018E, in USD Million
Table Spontanous / Trauma Production Volume by Region 2015-2018E, in Volume
Table Surgical Production Value by Region 2015-2018E, in USD Million
Table Surgical Production Volume by Region 2015-2018E, in Volume
Table Recombinant Factor VIII Market Size by Region 2015-2018E, in USD Million
Table Recombinant Factor VIII Market Size by Region 2015-2018E, in Volume
Table Plasma-derived Factor VIII Market Size by Region 2015-2018E, in USD Million
Table Plasma-derived Factor VIII Market Size by Region 2015-2018E, in Volume
Table Hemophilia A Market Size by Region 2015-2018E, in USD Million
Table Hemophilia A Market Size by Region 2015-2018E, in Volume
Table Spontanous / Trauma Market Size by Region 2015-2018E, in USD Million
Table Spontanous / Trauma Market Size by Region 2015-2018E, in Volume
Table Surgical Market Size by Region 2015-2018E, in USD Million
Table Surgical Market Size by Region 2015-2018E, in Volume
Table GlobalHuman Coagulation Factor VIII Forecast by Type 2019F-2025F, in USD Million
Table Human Coagulation Factor VIII Forecast by Type 2019F-2025F, in Volume
Table Human Coagulation Factor VIII Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Human Coagulation Factor VIII Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Human Coagulation Factor VIII Market Forecast by Region 2019F-2025F, in USD Million
Table Human Coagulation Factor VIII Market Forecast by Region 2019F-2025F, in Volume
Table Baxter Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of Baxter
Table Bayer Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of Bayer
Table CSL Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of CSL
Table Pfizer Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of Pfizer
Table Grifols Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of Grifols
Table Biogen Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of Biogen
Table Octapharma Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of Octapharma
Table NovoNordisk Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of NovoNordisk
Table Greencross Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of Greencross
Table Kedrion Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of Kedrion
Table BPL Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of BPL
Table Hualan Bio Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of Hualan Bio
Table RAAS Information
Table Human Coagulation Factor VIII Sales, Cost, Margin of RAAS
Table Global Human Coagulation Factor VIII Sales Revenue by Company 2015-2017, in USD Million
Table Global Human Coagulation Factor VIII Sales Volume by Company 2015-2017, in Volume
Table Global Human Coagulation Factor VIII Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Human Coagulation Factor VIII Picture
Figure Human Coagulation Factor VIII Industry Chain Diagram
Figure Global Human Coagulation Factor VIII Sales Revenue 2015-2018E, in USD Million
Figure Global Human Coagulation Factor VIII Sales Volume 2015-2018E, in Volume
Figure Global Human Coagulation Factor VIII Market Status by Type 2015-2018E, in Volume
Figure North America Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in USD Million
Figure North America Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in Volume
Figure Europe Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in USD Million
Figure Europe Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in Volume
Figure South America Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in USD Million
Figure South America Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in Volume
Figure Middle East Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in Volume
Figure Africa Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in USD Million
Figure Africa Human Coagulation Factor VIII Market Size and Growth 2015-2018E, in Volume
Figure Global Human Coagulation Factor VIII Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Human Coagulation Factor VIII Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Human Coagulation Factor VIII Sales Price Forecast 2019F-2025F
Figure Global Human Coagulation Factor VIII Gross Margin Forecast 2019F-2025F
Figure Global Human Coagulation Factor VIII Sales Revenue by Company in 2018, in USD Million
Figure Global Human Coagulation Factor VIII Price by Company in 2018
Figure Global Human Coagulation Factor VIII Gross Margin by Company in 2018

More Publications

Need Help?

Ask a Question

Market Reports

All Categories